CN108070045A - L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications - Google Patents

L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications Download PDF

Info

Publication number
CN108070045A
CN108070045A CN201611029571.3A CN201611029571A CN108070045A CN 108070045 A CN108070045 A CN 108070045A CN 201611029571 A CN201611029571 A CN 201611029571A CN 108070045 A CN108070045 A CN 108070045A
Authority
CN
China
Prior art keywords
amino acid
monomer
methacrylate
leu
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611029571.3A
Other languages
Chinese (zh)
Inventor
赵蕴慧
胡素利
胡文虹
李珍光
袁晓燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201811587688.2A priority Critical patent/CN109734855A/en
Priority to CN201611029571.3A priority patent/CN108070045A/en
Publication of CN108070045A publication Critical patent/CN108070045A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F122/00Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F122/10Esters
    • C08F122/1006Esters of polyhydric alcohols or polyhydric phenols, e.g. ethylene glycol dimethacrylate
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/38Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00Living radical polymerisation
    • C08F2438/03Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
  • Graft Or Block Polymers (AREA)

Abstract

The present invention discloses L cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications, block copolymerization preparation is carried out with monomer L lysines methacrylate and L leucine methyls acrylate, the first L-type amino acid monomer is subjected to homopolymerization first, using 4 cyanopentanoic acid of dithiobenzoic acid as chain-transferring agent, azodiisobutyronitrile carries out RAFT polymerizations for initiator, again by L-configuration amino acid monomer polymer macromolecule chain-transferring agent, azodiisobutyronitrile is initiator, it adds in the second L-type amino acid monomer and carries out RAFT polymerizations to obtain L lysines methacrylate and L leucine methyl acrylate block copolymers.The polymer of the present invention shows excellent anti-microbial property, can significantly destroy the death that bacterium membrane structure causes bacterium;Hemolytic experiment and external smooth muscle cell compatibility experiments show that it keeps significant biocompatibility.

Description

L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications
Technical field
The invention belongs to field of biomedical polymer materials, it is related to the design synthesis side of Novel imitation antibacterial peptide polymer Method, and in particular to a kind of preparation of cationic chiral amino acid methacrylate polymers and its antibacterial applications.
Background technology
At present, the appearance of antibiotic resistant bacteria brings great threat to publilc health health, the adherency of bacterium, Multiplication and the biomembrane formed can cause patient to infect and a series of complication triggered even to jeopardize patient vitals.It is although alternative The research of novel antibacterial polymer have been achieved with centainly being in progress, but it still has pole on bio-medical and clinical practice Big challenge.Alternative novel antibacterial polymer will not only have efficient anti-microbial property, while cannot influence body group Knit normal physiological action, in simple terms can the killing bacterium of selectivity and it is non-toxic to normal mammalian cell. Therefore, have both high-efficiency antimicrobial activity and the antibacterial polymer of selectivity still requires study.
The content of the invention
The purpose of the present invention is preparing a kind of cationic polymethacrylate polymer based on chiral amino acid, and Its application in antibiosis is studied, to overcome the shortcomings that existing antibacterial polymer antibacterial activity is weaker, biocompatibility is poor.
Present invention employs following technical schemes:
L-Leu methacrylate homopolymer, i.e. P (L-Leu-HEMA), with monomer D-Leu methacrylate Homopolymerization forms, and molecular formula schematic construction is as follows:
N is the degree of polymerization, and the number-average molecular weight of polymer is 10-23kDa, molecular weight distribution index 1.10-1.25.
The preparation method of above-mentioned homopolymer forms monomer L-Leu methacrylate homopolymerization, with two thio phenyl first Acid -4- cyanopentanoic acids are chain-transferring agent, and azodiisobutyronitrile carries out RAFT polymerizations, monomer L-Leu metering system for initiator The molar ratio of acid esters, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2.
In the above-mentioned technical solutions, carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is 60-80 degrees Celsius, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment.
In the above-mentioned technical solutions, monomer L-Leu methacrylate is prepared as steps described below:L- is bright Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein L-Leu, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), L-Leu are the L-Leu of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the homopolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by homopolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, due to Leu's Isoelectric point is pH 6.01, and the isoelectric point of Lys is pH 9.60, when adjusting pH is 7.2 ,-the NH of leu3 +Generation deprotonation, it is raw Into-NH2, shown in following chemical formula:
D-Leu methacrylate homopolymer, i.e. P (D-Leu-HEMA), with monomer D-Leu methacrylate Homopolymerization forms, and molecular formula schematic construction is as follows, and n is the degree of polymerization, and the number-average molecular weight of polymer is 10-23kDa, molecular weight distribution Coefficient is 1.10-1.25.
The preparation method of above-mentioned homopolymer forms monomer D-Leu methacrylate homopolymerization, with two thio phenyl first Acid -4- cyanopentanoic acids are chain-transferring agent, and azodiisobutyronitrile carries out RAFT polymerizations, monomer D-Leu metering system for initiator The molar ratio of acid esters, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2.
In the above-mentioned technical solutions, carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is 60-80 degrees Celsius, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment.
In the above-mentioned technical solutions, monomer D-Leu methacrylate is prepared as steps described below:D- is bright Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein D-Leu, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), D-Leu are the D-Leu of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the homopolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by homopolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, due to Leu's Isoelectric point is pH 6.01, and the isoelectric point of Lys is pH 9.60, when adjusting pH is 7.2 ,-the NH of leu3 +Generation deprotonation, it is raw Into-NH2, shown in following chemical formula:
L-lysine methacrylate homopolymer, i.e. P (L-Lys-HEMA), with monomer L-lysine methacrylate Homopolymerization forms, and molecular formula schematic construction is as follows, and n is the degree of polymerization, and the number-average molecular weight of polymer is 10-23kDa, molecular weight distribution Coefficient is 1.10-1.25.
The preparation method of above-mentioned homopolymer forms monomer L-lysine methacrylate homopolymerization, with two thio phenyl first Acid -4- cyanopentanoic acids are chain-transferring agent, and azodiisobutyronitrile carries out RAFT polymerizations, monomer L-lysine metering system for initiator The molar ratio of acid esters, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2.
In the above-mentioned technical solutions, carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is 60-80 degrees Celsius, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment.
In the above-mentioned technical solutions, monomer L-lysine methacrylate is prepared as steps described below:L- is relied Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein L-lysine, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), L-lysine are the L-lysine of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the homopolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by homopolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, adjusting pH is 7.2, lys is unaffected, shown in following chemical formula:
D-Lys methacrylate homopolymer, i.e. P (D-Leu-HEMA), with monomer D-Lys methacrylate Homopolymerization forms, and molecular formula schematic construction is as follows, and n is the degree of polymerization, and the number-average molecular weight of polymer is 10-23kDa, molecular weight distribution Coefficient is 1.10-1.25.
The preparation method of above-mentioned homopolymer forms monomer D-Lys methacrylate homopolymerization, with two thio phenyl first Acid -4- cyanopentanoic acids are chain-transferring agent, and azodiisobutyronitrile carries out RAFT polymerizations, monomer D-Lys metering system for initiator The molar ratio of acid esters, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2.
In the above-mentioned technical solutions, carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is 60-80 degrees Celsius, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment.
In the above-mentioned technical solutions, monomer D-Lys methacrylate is prepared as steps described below:D- is relied Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein D-Lys, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), D-Lys are the D-Lys of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the homopolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by homopolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, adjusting pH is 7.2, lys is unaffected, shown in following chemical formula:
D- cationic chiral amino acid methacrylate copolymers, it is bright with monomer D-Lys methacrylate and D- Propylhomoserin methacrylate carry out block copolymerization preparation, molecular formula schematic construction is as follows, n, m be respective monomer the degree of polymerization, m/n For (0.8-1.2), the consistent m=n of the degree of polymerization of preferably two kinds monomers, the number-average molecular weight of polymer is 10-23kDa, molecular weight Breadth coefficient is 1.10-1.25.
The preparation method of above-mentioned copolymer, is prepared as steps described below:
First D types amino acid monomer is carried out homopolymerization by step 1., using dithiobenzoic acid -4- cyanopentanoic acids as chain tra nsfer Agent, azodiisobutyronitrile carry out RAFT polymerizations to obtain D amino acids monomer-polymers, the first D type ammonia for initiator The molar ratio of base acid monomers, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2;
Step 2, the D amino acids monomer-polymer Macromolecular chain transfer agents that prepared by step 1, azodiisobutyronitrile are to draw Agent is sent out, the 2nd D types amino acid monomer is added in and carries out RAFT polymerizations to obtain D-Lys methacrylate and D-Leu first Base acrylate block copolymer, the molar ratio of the 2nd D types amino acid monomer, Macromolecular chain transfer agent and initiator are (80—100):1:0.2, preferably (85-90):1:0.2.
In the above-mentioned technical solutions, in step 1, carried out under inert gas (nitrogen, helium or argon gas) protection, instead Answering temperature, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and ring for 60-80 degrees Celsius Border.
In the above-mentioned technical solutions, in step 2, carried out under inert gas (nitrogen, helium or argon gas) protection, instead Answering temperature, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and ring for 60-80 degrees Celsius Border.
In the above-mentioned technical solutions, monomer D-Lys methacrylate is prepared as steps described below:D- is relied Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein D-Lys, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), D-Lys are the D-Lys of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, monomer D-Leu methacrylate is prepared as steps described below:D- is bright Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein D-Leu, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), D-Leu are the D-Leu of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the copolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by copolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, due to Leu's Isoelectric point is pH 6.01, and the isoelectric point of Lys is pH 9.60, when adjusting pH is 7.2 ,-the NH of leu3 +Generation deprotonation, it is raw Into-NH2, it is that 7.2, lys is unaffected to adjust pH, shown in following chemical formula:
L- cationic chiral amino acid methacrylate copolymers, it is bright with monomer L-lysine methacrylate and L- Propylhomoserin methacrylate carry out block copolymerization preparation, molecular formula schematic construction is as follows, n, m be respective monomer the degree of polymerization, m/n For (0.8-1.2), the consistent m=n of the degree of polymerization of preferably two kinds monomers, the number-average molecular weight of polymer is 10-23kDa, molecular weight Breadth coefficient is 1.10-1.25.
The preparation method of above-mentioned copolymer, is prepared as steps described below:
First L-type amino acid monomer is carried out homopolymerization by step 1., using dithiobenzoic acid -4- cyanopentanoic acids as chain tra nsfer Agent, azodiisobutyronitrile carry out RAFT polymerizations to obtain D amino acids monomer-polymers, the first L-type ammonia for initiator The molar ratio of base acid monomers, chain-transferring agent and initiator is (45-60):1:0.2, preferably (50-60):1:0.2;
Step 2, the L-configuration amino acid monomer polymer macromolecule chain-transferring agent that prepared by step 1, azodiisobutyronitrile are to draw Agent is sent out, the second L-type amino acid monomer is added in and carries out RAFT polymerizations to obtain L-lysine methacrylate and L-Leu first Base acrylate block copolymer, the molar ratio of the second L-type amino acid monomer, Macromolecular chain transfer agent and initiator are (80—100):1:0.2, preferably (85-90):1:0.2.
In the above-mentioned technical solutions, in step 1, carried out under inert gas (nitrogen, helium or argon gas) protection, instead Answering temperature, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and ring for 60-80 degrees Celsius Border.
In the above-mentioned technical solutions, in step 2, carried out under inert gas (nitrogen, helium or argon gas) protection, instead Answering temperature, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and ring for 60-80 degrees Celsius Border.
In the above-mentioned technical solutions, monomer L-lysine methacrylate is prepared as steps described below:L- is relied Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein L-lysine, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), L-lysine are the L-lysine of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, monomer L-Leu methacrylate is prepared as steps described below:L- is bright Propylhomoserin and hydroxyethyl methacrylate are using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide for dehydration contract Mixture reacts 30-60 minutes by solvent of dichloromethane in ice-water bath, is stirred to react under 20-25 degrees Celsius of room temperature When 24-48 is small, wherein L-Leu, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate Mass ratio be 5:(0.2—0.25):(4—5):(2-3), L-Leu are the L-Leu of tertbutyloxycarbonyl protection.
In the above-mentioned technical solutions, the copolymer of preparation is deprotected under trifluoroacetic acid effect, preferably by copolymer It is dissolved in dichloromethane, under trifluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, after purification Dissolving dialysis, freeze-drying.
Due to being acted on using trifluoroacetic acid, with trifluoroacetic acid group in the polymer after deprotection reaction, due to Leu's Isoelectric point is pH 6.01, and the isoelectric point of Lys is pH 9.60, when adjusting pH is 7.2 ,-the NH of leu3 +Generation deprotonation, it is raw Into-NH2, it is that 7.2, lys is unaffected to adjust pH, shown in following chemical formula:
The present invention provides a kind of method of regulation and control copolymer overall configuration, i.e., is total to using the monomer of D configurations and L-configuration It is poly-, by the ingredient proportion of D types/L-type monomer, molar ratio between the two is changed, so that copolymer shows as D types or L-type, Application of the i.e. controllable living polymerization in leucine-lysine methacrylate copolymer chirality is regulated and controled.
Using reversible addion-fragmentation chain transfer polymerization by the ingredient proportion of D types/L-type monomer, change is between the two Molar ratio so that copolymer shows as D types or L-type, i.e., by D types and the ingredient proportion of L-type monomer, change in copolymer Molar ratio between D types monomer and L-type monomer, so that copolymer general performance is D types or L-type.
For above-mentioned four kinds of monomers, polymer that homopolymerization obtains shows the D and L-configuration consistent with corresponding monomer, and two The copolymer that a L-type monomer copolymerization obtains shows as L-type, and the copolymer that two D type monomer copolymerizations obtain shows as D types, copolymerization Object is copolymerized using D types and L-type monomer, adjusts the relative populations of D types monomer and L-type monomer, you can realizes that copolymer is whole Configuration shows controllable.
In the technical solution of the present invention, the control of (i.e. monomer molar ratio) of adding materials can be realized using living polymerization, Reaction condition is mild, and synthon yield is 70%-85%, polymerization conversion 50%-90%, homopolymer and copolymer Molecular weight it is controllable and breadth coefficient is relatively narrow.
The invention discloses based on chiral amino acid methacrylate polymers and preparation method thereof and antibacterial applications.Circle Dichroscope spectrum characterization result proves that above-mentioned obtained L-configuration and D configurations polymer have opposite deuterostrophies structure.Microdilution Antibacterial experiment research show the dialysis of above-mentioned gained it is lyophilized after the methacrylate polymers based on chiral amino acid minimum suppression Bacteria concentration (MIC) is 100~1000 μ gmL-1, excellent anti-microbial property is shown, field emission scanning electron microscope result figure is intuitively The death that bacterium membrane structure causes bacterium can significantly be destroyed by showing antibacterial polymer produced by the present invention;Hemolytic experiment and External smooth muscle cell compatibility experiments show cationic chiral amino acid methacrylate antimicrobial polymerizable prepared by the present invention Object can still keep significant biocompatibility under concentration needed for antibacterial, and wherein hemolysis rate is less than 10%, and smooth muscle cell is lived Property can reach more than 80%.
Description of the drawings
Fig. 1 is the mechanism of polymerization schematic diagram of reversible addion-fragmentation chain transfer polymerization (RAFT) in the present invention.
Fig. 2 be in the present invention monomer D-Leu (Boc)-HEMA in CDCl3In1H-NMR spectrum.
Fig. 3 be in the present invention monomer D-Lys (Boc)-HEMA in CDCl3In1H-NMR spectrum.
Fig. 4 is P (D-Leu (Boc)-HEMA) homopolymer (1) not being deprotected in the present invention, P (D-Lys (Boc)-HEMA) Homopolymer (2) and P (D-Leu (Boc)-HEMA)-b-P (D-Lys (Boc)-HEMA) block copolymer (3) are in CDCl3In1H- NMR spectra.
Fig. 5 be in the present invention be deprotected after P (D-Leu-HEMA) homopolymer (1), P (D-Lys-HEMA) homopolymer homopolymer (2) and P (D-Leu-HEMA)-b-P (D-Lys-HEMA) block copolymer homopolymers (3) are in D2In O1H-NMR spectrum.
Fig. 6 is the circular dichroism spectra characterization result figure of homopolymer and copolymer in the present invention.
Fig. 7 is the stereoscan photograph of polymer antibacterial experiment in the present invention.
Fig. 8 is the antibacterial experiment effect curve figure (1) that polymer is directed to Escherichia coli in the present invention.
Fig. 9 is the antibacterial experiment effect curve figure (1) that polymer is directed to staphylococcus aureus in the present invention.
Figure 10 is the biocompatibility in vitro phenogram of Inventive polymers P (L-Leu-HEMA).
Figure 11 is the biocompatibility in vitro phenogram of Inventive polymers P (D-Leu-HEMA).
Figure 12 is the biocompatibility in vitro phenogram of Inventive polymers P (D-Leu-HEMA-b-D-Lys-HEMA).
Figure 13 is the biocompatibility in vitro phenogram of Inventive polymers P (L-Leu-HEMA-b-L-Lys-HEMA).
Specific embodiment
The technical solution further illustrated the present invention with reference to specific embodiment.The experimental raw and instrument that embodiment uses Device difference is as shown in the table:
(1) experimental raw
(2) laboratory apparatus
Polymerize in embodiments of the present invention using reversible addion-fragmentation chain transfer, RAFT polymerizations be a kind of activity/controllable from It is polymerize by base, is applicable in the monomer containing double bond functional group.In RAFT polymerizations, conventional initiator is thermally decomposed into primary group of free radicals I., and trigger monomer polymerization into Propagating Radical Pn ., the C=S keys in Propagating Radical and chain-transferring agent carry out reversible addition shape Into intermediate dormancy kind, S-R keys are broken in dormancy kind, form new reactive species free radical Rn ., then trigger monomer polymerization, react machine Reason is illustrated in fig. 1 shown below.Different from conventional free radical polymerization, RAFT polymerization chain tra nsfers are reversible process, intermediate dormancy kind and life The balanced reaction of reversible addition and reversible fracture is carried out between long-chain free radical, so that it is guaranteed that all chains are given birth to equal probability It is long, form the polymer of narrow ditribution, number of free radical maintains a relative constant reduced levels in system, in inhibition system The biradical termination reaction of free radical so that polymerization activity is controllable.Initiator is used in the present invention and triggers the first monomer, with the One monomer and chain-transferring agent carry out living polymerization, and when adding in second comonomer, supplement initiator is to trigger second comonomer, with activity It polymerize the living polymerization that the first obtained monomer homopolymers carry out second comonomer for Macromolecular chain transfer agent.
Embodiment 1-prepare monomer D-Leu hydroxyethyl methacrylate, L-Leu hydroxyethyl methacrylate, D- Lysine hydroxyethyl methacrylate and L-lysine hydroxyethyl methacrylate
The chiral amino acid monomer 5g for being dissolved in 22mL dry methylene chlorides is added in first into dry neck round bottom flask (it is respectively D-Leu, L-Leu, D-Lys and L-lysine, to ensure the activity of functional group in reaction, selects tertiary fourth The boc-protected above-mentioned four kinds of amino acid of oxygen carbonyl, sloughs Boc protecting groups using trifluoroacetic acid after reacting), in magnetic agitation Logical nitrogen purification down, then adds in the catalyst DMAP 0.24g for being dissolved in 1.5mL dry methylene chlorides, reaction bulb is placed in ice water It in bath, is slowly added to be dissolved in the dehydrating condensation agent DCC 4.53g of 20mL dry methylene chlorides dropwise, and exists under nitrogen protection 2.86g HEMA are added in 20min.30min is reacted under ice-water bath, under subsequent nitrogen atmosphere under 20-25 degrees Celsius of room temperature The reaction was continued 36h.It filters after reaction and removes white precipitate, obtained organic mixed solution 70mL distilled water and 100mL Dichloromethane extracts four times, and obtained organic layer is further extracted twice with 60mL0.1mol/L hydrochloric acid solutions successively, and 60mL satisfies It is washed twice with sodium bicarbonate solution and 60mL saturated nacl aqueous solutions.It is finally dried, is stirred overnight with anhydrous sodium sulfate, filtered Afterwards, revolving removes solvent.
Four kinds of monomers of preparation are characterized using nuclear magnetic resonance, as a result as shown in Figures 2 and 3, in view of four kinds of monomers Chemical composition be divided into two kinds (i.e. leucine methyl hydroxy-ethyl acrylates and lysine hydroxyethyl methacrylate), chemical structure It is divided into D and L, the nuclear magnetic spectrogram of the various configuration of same chemical composition is basically identical, is understood as shown in two attached drawings, nuclear-magnetism is common The chemical shift shaken corresponds to the hydrogen atom of the different chemical environments marked in chemical formula, exactly proves that four kinds of monomers are successfully prepared.
Embodiment 2-and using four kinds of monomers of the preparation of embodiment 1 as raw material, reversible addion-fragmentation chain transfer is used to polymerize and is made Standby four kinds of homopolymers
Cationic chiral amino acid hydroxyethyl methacrylate homopolymer is prepared using RAFT polymerizations:With magnetic force In Schlenk bottles of the 25mL of stirrer, add in monomer made from 1.5g embodiments 1, CPADB 24.4mg, AIBN 2.86mg and 1.5g anhydrous DMF solvents-are taken out-by freezing three times after melting the foreign gas that Xun Huan is removed in reaction system, are placed in 70 DEG C of oil bath In pot, when reaction 10 is small under nitrogen protection.After the completion of reaction, exposure is placed in being quickly cooled down termination in ice-water bath in air Reaction, then with acetone/n-hexane repeated precipitation 5 times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h, is obtained The sample of each homopolymer.Under the conditions of ice-water bath, the ratio of 20mL dichloromethane and 10mL trifluoroacetic acids is added according to every 1g samples Example, is added in reaction bulb, then in room temperature reaction 3h, rotates to remove solvent.Products therefrom is added dropwise to anhydrous ether, instead Multiple precipitation is three times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h.Product after purification is dissolved in deionization In water, dialysis 72h removes remaining impurity, and pure spongy solid sample is obtained after freeze-drying.
Four kinds of homopolymers of preparation are characterized using nuclear magnetic resonance, as a result as shown in figs. 4 and 5, similarly based on bright There are the difference (D of chemical structure for the two kinds of polymer of propylhomoserin hydroxyethyl methacrylate and lysine hydroxyethyl methacrylate Type and L-type), the nuclear magnetic spectrogram of the various configuration of same chemical composition is basically identical, is understood as shown in two attached drawings, nuclear-magnetism is common The chemical shift shaken corresponds to the hydrogen atom of the different chemical environments marked in chemical formula, exactly proves that four kinds of homopolymers are successfully made It is standby, and block polymer does not generate variation after deprotection.
Embodiment 3-preparation D- cationic chiral amino acid hydroxyethyl methacrylate copolymers
(1) homopolymer of D-leucine is prepared first using the method for embodiment 2:In the 25mL with magnetic stir bar In Schlenk bottles, add in monomer D-leucine methyl hydroxy-ethyl acrylate prepared by 1.5g embodiments 1, CPADB 24.4mg, AIBN 2.86mg and 1.5g anhydrous DMF solvents-are taken out-by freezing three times after melting the foreign gas that Xun Huan is removed in reaction system, It is placed in 70 DEG C of oil bath pan, when reaction 10 is small under nitrogen protection, after treating that reaction is basic, without the end of exposure air Only react, and what the active group (CPADB) for being to maintain D-leucine homopolymer end was reacted as addition second comonomer Macromolecular chain transfer agent;
(2) in reaction vessel, lysine methacrylate monomers (the i.e. D-lysine first of 3g identical configurations is added in Base hydroxy-ethyl acrylate), AIBN 2.15mg and with 3g anhydrous DMF solvents, with the Macromolecular chain transfer agent 0.96g prepared before It is reacted ,-takes out-after melting the foreign gas that Xun Huan is removed in reaction system, be placed in 70 DEG C of oil bath pan by freezing three times, When the lower reaction 6 of nitrogen protection is small, obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h after multiple deposition and purification;
(3) under the conditions of ice-water bath, 20mL dichloromethane is added according to every 1g samples (sample that i.e. above-mentioned steps 2 obtain) It with the ratio of 10mL trifluoroacetic acids, is added in reaction bulb, then in room temperature reaction 3h, rotates to remove solvent.Gained is produced Object is added dropwise to anhydrous ether, and repeated precipitation is three times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h.It will purifying Product afterwards is dissolved in deionized water, and dialysis 72h removes remaining impurity, and pure spongy solid sample is obtained after freeze-drying Product.Obtain the cationic chiral amino acid hydroxyethyl methacrylate copolymer of D configurations.
The cationic chiral amino acid hydroxyethyl methacrylate copolymer of the D configurations of preparation is carried out using nuclear magnetic resonance Characterization, as shown in figs. 4 and 5, the chemical shift of nuclear magnetic resonance corresponds to the hydrogen atom of the different chemical environments marked in chemical formula, Exactly prove that copolymer is successfully prepared, and block polymer does not generate variation after deprotection.
Embodiment 4-preparation L- cationic chiral amino acid methacrylate copolymers
(1) homopolymer of L-leucine is prepared first using the method for embodiment 2:In the 25mL with magnetic stir bar In Schlenk bottles, add in monomer L-leucine methyl hydroxy-ethyl acrylate prepared by 1.5g embodiments 1, CPADB 24.4mg, AIBN 2.86mg and 1.5g anhydrous DMF solvents-are taken out-by freezing three times after melting the foreign gas that Xun Huan is removed in reaction system, It is placed in 70 DEG C of oil bath pan, when reaction 10 is small under nitrogen protection, after treating that reaction is basic, without the end of exposure air Only react, and what the active group (CPADB) for being to maintain L-leucine homopolymer end was reacted as addition second comonomer Macromolecular chain transfer agent;
(2) in reaction vessel, lysine methacrylate monomers (the i.e. L-lysine first of 3g identical configurations is added in Base hydroxy-ethyl acrylate), AIBN 2.15mg and with 3g anhydrous DMF solvents, with the Macromolecular chain transfer agent 0.96g prepared before It is reacted ,-takes out-after melting the foreign gas that Xun Huan is removed in reaction system, be placed in 70 DEG C of oil bath pan by freezing three times, When the lower reaction 6 of nitrogen protection is small, obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h after multiple deposition and purification;
(3) under the conditions of ice-water bath, 20mL dichloromethane is added according to every 1g samples (sample that i.e. above-mentioned steps 2 obtain) It with the ratio of 10mL trifluoroacetic acids, is added in reaction bulb, then in room temperature reaction 3h, rotates to remove solvent.Gained is produced Object is added dropwise to anhydrous ether, and repeated precipitation is three times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h.It will purifying Product afterwards is dissolved in deionized water, and dialysis 72h removes remaining impurity, and pure spongy solid sample is obtained after freeze-drying Product.Obtain the cationic chiral amino acid hydroxyethyl methacrylate copolymer of L-configuration.
The copolymer of preparation is characterized using nuclear magnetic resonance, the cationic chiral ammonia of the D configurations prepared with embodiment 3 Base acids methacrylic acid hydroxyl ethyl ester copolymer is compared, and only there is different (L-types), the chemical environment basic one of hydrogen atom in configuration It causes, i.e. the chemical shift of D types and L-type is basically identical, and as a result as shown in figs. 4 and 5, the chemical shift of nuclear magnetic resonance corresponds to chemistry The hydrogen atom of the different chemical environments marked in formula exactly proves that copolymer is successfully prepared, and the bulk polymerization after deprotection Object does not generate variation.
Embodiment 5-prepare D-Lys/L-Leu methacrylate copolymer
(1) homopolymer of L-leucine is prepared first using the method for embodiment 2:In the 25mL with magnetic stir bar In Schlenk bottles, add in monomer L-leucine methyl hydroxy-ethyl acrylate prepared by 1.5g embodiments 1, CPADB 24.4mg, AIBN 2.86mg and 1.5g anhydrous DMF solvents-are taken out-by freezing three times after melting the foreign gas that Xun Huan is removed in reaction system, It is placed in 70 DEG C of oil bath pan, when reaction 10 is small under nitrogen protection, after treating that reaction is basic, without the end of exposure air Only react, and what the active group (CPADB) for being to maintain L-leucine homopolymer end was reacted as addition second comonomer Macromolecular chain transfer agent;
(2) in reaction vessel, lysine methacrylate monomers (the i.e. D-lysine first of 3g various configurations is added in Base hydroxy-ethyl acrylate), AIBN 2.15mg and with 3g anhydrous DMF solvents, with the Macromolecular chain transfer agent 0.96g prepared before It is reacted ,-takes out-after melting the foreign gas that Xun Huan is removed in reaction system, be placed in 70 DEG C of oil bath pan by freezing three times, When the lower reaction 6 of nitrogen protection is small, obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h after multiple deposition and purification;
(3) under the conditions of ice-water bath, 20mL dichloromethane is added according to every 1g samples (sample that i.e. above-mentioned steps 2 obtain) It with the ratio of 10mL trifluoroacetic acids, is added in reaction bulb, then in room temperature reaction 3h, rotates to remove solvent.Gained is produced Object is added dropwise to anhydrous ether, and repeated precipitation is three times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h.It will purifying Product afterwards is dissolved in deionized water, and dialysis 72h removes remaining impurity, and pure spongy solid sample is obtained after freeze-drying Product obtain D-Lys/L-Leu methacrylate copolymer.
Embodiment 6-prepare D-Leu/L-lysine methacrylate copolymer
(1) homopolymer of D-leucine is prepared first using the method for embodiment 2:In the 25mL with magnetic stir bar In Schlenk bottles, add in monomer D-leucine methyl hydroxy-ethyl acrylate prepared by 1.5g embodiments 1, CPADB 24.4mg, AIBN 2.86mg and 1.5g anhydrous DMF solvents-are taken out-by freezing three times after melting the foreign gas that Xun Huan is removed in reaction system, It is placed in 70 DEG C of oil bath pan, when reaction 10 is small under nitrogen protection, after treating that reaction is basic, without the end of exposure air Only react, and what the active group (CPADB) for being to maintain D-leucine homopolymer end was reacted as addition second comonomer Macromolecular chain transfer agent;
(2) in reaction vessel, lysine methacrylate monomers (the i.e. L-lysine first of 3g various configurations is added in Base hydroxy-ethyl acrylate), AIBN 2.15mg and with 3g anhydrous DMF solvents, with the Macromolecular chain transfer agent 0.96g prepared before It is reacted ,-takes out-after melting the foreign gas that Xun Huan is removed in reaction system, be placed in 70 DEG C of oil bath pan by freezing three times, When the lower reaction 6 of nitrogen protection is small, obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h after multiple deposition and purification;
(3) under the conditions of ice-water bath, 20mL dichloromethane is added according to every 1g samples (sample that i.e. above-mentioned steps 2 obtain) It with the ratio of 10mL trifluoroacetic acids, is added in reaction bulb, then in room temperature reaction 3h, rotates to remove solvent.Gained is produced Object is added dropwise to anhydrous ether, and repeated precipitation is three times.Obtained product is placed in 30 DEG C of vacuum drying chamber dry 8h.It will purifying Product afterwards is dissolved in deionized water, and dialysis 72h removes remaining impurity, and pure spongy solid sample is obtained after freeze-drying Product.Obtain D-Leu/L-lysine methacrylate copolymer.
The polymer obtained by four kinds of monomer homopolymerizations shows the D and L-configuration consistent with corresponding monomer, two L-type monomers It is copolymerized obtained copolymer and shows as L-type, the copolymer that two D type monomer copolymerizations obtain shows as D types, prepared by embodiment 5 and 6 Copolymer be copolymerized using D types and L-type monomer, can rubbing between the two be changed by the ingredient proportion of D types/L-type monomer That ratio, so that copolymer shows as D types or L-type, i.e., passes through D types and L-type using reversible addion-fragmentation chain transfer polymerization The ingredient proportion of monomer changes the molar ratio between D types monomer and L-type monomer in copolymer, so that copolymer general performance is D Type or L-type.
7-homopolymer of embodiment, the test of copolymer property
As shown in fig. 6, the D configurations of preparation and L-configuration polymer are subjected to circular dichroism spectra test, in identical wave-length coverage Interior appearance upward wave crest and downward trough, the corresponding polymer of upward wave crest is L-configuration, to the corresponding polymer of lower wave trough For D configurations, antipodal helical conformation is shown.
Microdilution antibacterial experiment bibliography:P.Li,C.C.Zhou,S.Rayatpisheh,K.Ye,Y.F.Poon, P.T.Hammond,H.W.Duan,M.B.Chan-Park,Adv.Mater.,2012,24,4130-4137;External human aorta Smooth muscle cell compatibility experiments bibliography:S.E.Exley,L.C.Paslay,G.S.Sahukhal,B.A.Abel, T.D.Brown,C.L.McCormick,S.Heinhorst,V.Koul,V.Choudhary,M.O.Elasri,S.E.Morgan, Biomacromolecules,2015,16,3845-3852;Hemolytic experiment bibliography:A.Pascual,J.P.K.Tan, A.Yuen,J.M.W.Chan,D.J.Coady,D.Mecerreyes,J.L.Hedrick,Y.Y.Yang,H.Sardon, Biomacromolecules,2015,16,1169-1178。
Staphylococcus aureus is selected to be represented for gram-positive bacteria, Escherichia coli represent for Gram-negative bacteria, first Bacterium bacterial strain is incubated overnight and reaches growth medium, every milliliter 3 × 10 is diluted to PBS buffer solution8A Colony Forming Unit (CFU), Polymer Solution (aqueous solution of the polymer of preparation) aseptic liquid nutrient medium doubling dilution is secondly taken into 100 μ L The bacterial suspension diluted is added in 96 orifice plates in the Polymer Solution of 100 μ L, and the ultimate density for obtaining antibacterial polymer is 2-4096μg·mL-1.96 orifice plates are then placed in 37 DEG C of culture 18h, use absorbance of the microplate reader test microvia at 600nm Value.Using bacterial cell culture solutions of the 200 μ L without antibacterial polymer as positive controls, culture solution pure 200 μ L is feminine gender Control group.Experiment is respectively provided with 4-6 parallel sample every time.Simultaneously a series of control group of concentration polymer solutions is set to exclude Influence of the polymer solution to experimental group absorbance.It then, will with the glutaraldehyde phosphate buffer of 2.5% percentage by volume Bacterium (20-25 degrees Celsius) the fixed 4h at room temperature of polymer solution culture contact 3h by 100 μ L lethal doses, and With PBS buffer solution rinsing twice, 15min is then dehydrated successively by the ethanol solution of gradient concentration, is centrifuged under 1000rpm 10min, it was evenly coated on silicon chip, natural air drying, metal spraying 50s observes bacterium under field emission scanning electron microscope Surface breakdown pattern.
As shown in Figure 7, antibacterial polymer produced by the present invention is intuitively shown from field emission scanning electron microscope result figure The death that bacterium membrane structure causes bacterium can be significantly destroyed, and the polymer according to above-described embodiment preparation is shown and base This consistent performance.As shown in figs. 8 and 9, P (D-Leu-HEMA) homopolymer, P (D-Lys-HEMA) homopolymers and P (D-Leu- HEMA)-b-P (D-Lys-HEMA) block copolymer shows excellent anti-microbial property, the experimental results showed that, P (D-Leu- HEMA) minimum inhibitory concentration (MIC) of homopolymer is 798~820 μ gmL-1, the MIC of P (D-Lys-HEMA) homopolymer is 100 ~120 μ gmL-1, the MIC of P (D-Leu-HEMA)-b-P (D-Lys-HEMA) block copolymer is 180~200 μ gmL-1 (showing basically identical situation for Escherichia coli and staphylococcus aureus);Use the homopolymer based on L-type amino acid instead And copolymer, show the homopolymer and copolymer with the basically identical anti-microbial property of above-described embodiment, slightly below D type amino acid. The copolymer being copolymerized using D types and L-type monomer, by adjusting the ingredient proportion of D types/L-type monomer, copolymer shows as D Type or L-type equally have the anti-microbial property consistent with respective configuration, less than the anti-microbial property of respective configuration.
As shown in attached drawing 10-13, hemolytic experiment and external human aortic smooth muscle cell's compatibility experiments show this hair The polymer of bright preparation can still keep significant biocompatibility under concentration needed for antibacterial, and wherein hemolysis rate is less than 10%, Smooth muscle cell activity can reach more than 80%.
The preparation of above-mentioned polymer is carried out according to present invention, polymer shows the property basically identical with embodiment Energy.Illustrative description is done to the present invention above, it should which explanation in the case where not departing from the core of the present invention, is appointed What simple deformation, modification or other skilled in the art can not spend the equivalent substitution of creative work to each fall within this The protection domain of invention.

Claims (10)

1.L- cationic chiral amino acid methacrylate copolymers, which is characterized in that with monomer L-lysine metering system Acid esters and L-Leu methacrylate carry out block copolymerization preparation, and molecular formula schematic construction is as follows, n, and m is respective monomer The degree of polymerization.
2. L- cationic chirals amino acid methacrylate copolymer according to claim 1, which is characterized in that m/n For (0.8-1.2), the consistent m=n of the degree of polymerization of preferably two kinds monomers.
3. L- cationic chirals amino acid methacrylate copolymer according to claim 1, which is characterized in that polymerization The number-average molecular weight of object is 10-23kDa, molecular weight distribution index 1.10-1.25.
The preparation method of 4.L- cationic chiral amino acid methacrylate copolymers, which is characterized in that as steps described below It is prepared:
First L-type amino acid monomer is carried out homopolymerization by step 1., even using dithiobenzoic acid -4- cyanopentanoic acids as chain-transferring agent Nitrogen bis-isobutyronitrile carries out RAFT polymerizations to obtain D amino acids monomer-polymers, the first L-type amino acid list for initiator The molar ratio of body, chain-transferring agent and initiator is (45-60):1:0.2;
Step 2, the L-configuration amino acid monomer polymer macromolecule chain-transferring agent that prepared by step 1, azodiisobutyronitrile are initiation Agent adds in the second L-type amino acid monomer and carries out RAFT polymerizations to obtain L-lysine methacrylate and L-Leu methyl Acrylate block copolymer, the molar ratio of the second L-type amino acid monomer, Macromolecular chain transfer agent and initiator are (80—100):1:0.2.
5. the preparation method of L- cationic chirals amino acid methacrylate copolymer according to claim 4, special Sign is, in step 1, is carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is Celsius for 60-80 Degree, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment;First L-type amino acid list The molar ratio of body, chain-transferring agent and initiator is (50-60):1:0.2.
6. the preparation method of L- cationic chirals amino acid methacrylate copolymer according to claim 4, special Sign is, in step 2, is carried out under inert gas (nitrogen, helium or argon gas) protection, reaction temperature is Celsius for 60-80 Degree, when the reaction time is 6-10 small, solvent n,N-Dimethylformamide provides reaction atmosphere and environment;Second L-type amino acid list The molar ratio of body, Macromolecular chain transfer agent and initiator is (85-90):1:0.2.
7. the preparation method of L- cationic chirals amino acid methacrylate copolymer according to claim 4, special Sign is that monomer L-lysine methacrylate is prepared as steps described below:By L-lysine and hydroxyethyl methacrylate Ethyl ester is using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide be dehydrating condensation agent, using dichloromethane to be molten Agent is reacted 30-60 minutes in ice-water bath, be stirred to react under 20-25 degrees Celsius of room temperature 24-48 it is small when, wherein L- relies ammonia The mass ratio of acid, 4-dimethylaminopyridine, N, N '-dicyclohexylcarbodiimide and hydroxyethyl methacrylate is 5:(0.2— 0.25):(4—5):(2-3), L-lysine are the L-lysine of tertbutyloxycarbonyl protection;Monomer L-Leu methacrylic acid Ester is prepared as steps described below:By L-Leu and hydroxyethyl methacrylate using 4-dimethylaminopyridine as catalyst, N, N '-dicyclohexylcarbodiimide be dehydrating condensation agent, reacted by solvent of dichloromethane in ice-water bath 30-60 minutes, then Be stirred to react under 20-25 degrees Celsius of room temperature 24-48 it is small when, wherein L-Leu, 4-dimethylaminopyridine, N ,-two hexamethylenes of N ' The mass ratio of base carbodiimide and hydroxyethyl methacrylate is 5:(0.2—0.25):(4—5):(2-3), L-Leu are The L-Leu of tertbutyloxycarbonyl protection.
8. the preparation method of L- cationic chirals amino acid methacrylate copolymer according to claim 4, special Sign is that the copolymer of preparation is deprotected under trifluoroacetic acid effect, preferably copolymer is dissolved in dichloromethane, three Under fluoroacetic acid effect, when progress deprotection reaction 2-4 is small under 20-25 degrees Celsius, dissolving dialysis, freeze-drying after purification is It can.
9. the L- cationic chiral amino acid methacrylate copolymers as described in claims 1 or 2 or 3 are in antibacterial Application, which is characterized in that 100~1000 μ gmL of minimum inhibitory concentration average out to-1, polymer can destroy bacterium membrane structure Cause the death of bacterium, and keep significant biocompatibility.
10. application according to claim 9, which is characterized in that bacterium is staphylococcus aureus or Escherichia coli.
CN201611029571.3A 2016-11-14 2016-11-14 L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications Pending CN108070045A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201811587688.2A CN109734855A (en) 2016-11-14 2016-11-14 The preparation method of L- cationic chiral amino acid methacrylate copolymer
CN201611029571.3A CN108070045A (en) 2016-11-14 2016-11-14 L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611029571.3A CN108070045A (en) 2016-11-14 2016-11-14 L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201811587688.2A Division CN109734855A (en) 2016-11-14 2016-11-14 The preparation method of L- cationic chiral amino acid methacrylate copolymer

Publications (1)

Publication Number Publication Date
CN108070045A true CN108070045A (en) 2018-05-25

Family

ID=62161300

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201611029571.3A Pending CN108070045A (en) 2016-11-14 2016-11-14 L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications
CN201811587688.2A Pending CN109734855A (en) 2016-11-14 2016-11-14 The preparation method of L- cationic chiral amino acid methacrylate copolymer

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201811587688.2A Pending CN109734855A (en) 2016-11-14 2016-11-14 The preparation method of L- cationic chiral amino acid methacrylate copolymer

Country Status (1)

Country Link
CN (2) CN108070045A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113925060A (en) * 2021-09-13 2022-01-14 浙江理工大学 Nano ZnO loaded antibacterial polymer and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775530A (en) * 2012-05-30 2012-11-14 江南大学 RAFT (reversible addition fragmentation chain transfer) preparation method of polylysine derivative
CN103193926A (en) * 2013-04-18 2013-07-10 苏州大学 Copolymer containing lysine residue on side chain and preparation method thereof as well as fibrinolytic functional material

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103665222A (en) * 2012-09-24 2014-03-26 中国科学院上海有机化学研究所 Cation functional polymers with natural amino acid as side group, preparation method and application of polymer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775530A (en) * 2012-05-30 2012-11-14 江南大学 RAFT (reversible addition fragmentation chain transfer) preparation method of polylysine derivative
CN103193926A (en) * 2013-04-18 2013-07-10 苏州大学 Copolymer containing lysine residue on side chain and preparation method thereof as well as fibrinolytic functional material

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113925060A (en) * 2021-09-13 2022-01-14 浙江理工大学 Nano ZnO loaded antibacterial polymer and preparation method and application thereof

Also Published As

Publication number Publication date
CN109734855A (en) 2019-05-10

Similar Documents

Publication Publication Date Title
CN110437374B (en) Quaternary ammonium salt amphiphilic cationic polymer and application thereof
CN108329467A (en) A kind of preparation method of novel hyperbranched antibacterial peptide polymer
CN103403047B (en) Covalently bound anti-microbial polymer
JP2021512862A (en) Branched polyamino acid antimicrobial agent and its use
Wang et al. Cell adhesion and accelerated detachment on the surface of temperature-sensitive chitosan and poly (N-isopropylacrylamide) hydrogels
CN109847085A (en) A kind of anti-infective Wound dressing and preparation method thereof that stops blooding
CN110527080A (en) Amphipathic multi-block class antibacterial peptide copolymer and its preparation method and application
Zhang et al. Synthesis of novel guanidine-based ABA triblock copolymers and their antimicrobial honeycomb films
WO2020228758A1 (en) Method for preparing cationic antimicrobial polypeptoid polymer simulating natural antimicrobial peptide structure
CN107286355A (en) Cationically ampholytic ionic copolymer and polycaprolactone blend film and its preparation method and application
CN114392388A (en) Hydrogel composition and application thereof
CN107011473B (en) Leucine methyl Voncoat R 3310 and preparation method and the application in antibacterial
Xue et al. A sulfonate-based polypeptide toward infection-resistant coatings
CN108070045A (en) L- cationic chiral amino acid methacrylate copolymers and preparation and antibacterial applications
CN107011472B (en) Application of the controllable living polymerization in regulation leucine-lysine methacrylate copolymer chirality
CN108070062B (en) D- cationic chiral amino acid methacrylate copolymer and preparation and antibacterial applications
CN110028614A (en) The micro-nano gel of antibacterial and fiber with protein adsorption function and preparation method thereof
CN108070043A (en) Lysine methacrylate homopolymer and preparation method and the application in antibacterial
Sh et al. The research of antibacterial properties of methyl methacrylate and methacryloyl salicylate copolymers
Morro et al. Inherent antibacterial activity and in vitro biocompatibility of hydrophilic polymer film containing chemically anchored sulfadiazine moieties
CN110511624B (en) Preparation method of coating with sterilization and bacterial release effects and product thereof
Singh et al. Radiation induced grafting of methacrylic acid onto silk for the immobilization of antimicrobial drug for sustained delivery
Chen et al. Synthesis and characterization of poly (vinyl alcohol) membranes with quaternary ammonium groups for wound dressing
CN114195934B (en) UCST type polymer with bacterial targeting function, preparation method and application
CN108003740A (en) A kind of antibacterial polymer of blood compatibility and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180525

RJ01 Rejection of invention patent application after publication